In recent months three compounding executives have been criminally charged after producing harmful medicines, including morphine for infants that was over 2,000 percent more potent than labeled, and FDA's top lawyer said Wednesday (Dec. 6) that the agency is dedicating significant resources to enforcing compounding regulations and is working with the Department of Justice in certain situations to shut down out-of-compliance compounders. FDA officials acknowledge that the agency continues to observe "egregious conditions," including insanitary conditions which in some cases...